Delivery Order SPE2DB22D1202-SPE2DB25FUNU2
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.57 firm fixed-price delivery order is for the supply of 4566661219 ENGERIX-B 20 MCG/ML SYRNML, with a completion date of December 10, 2024. This contract is not designated under any set-aside program.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,356.10 to Amerisourcebergen Drug Corporation's Corporate Office division. This Firm Fixed Price contract is for the supply of 4564559769 ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product, with a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,030.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML pharmaceutical products. This delivery order has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The company holds an Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,287,421 units of the ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine. The $3,970.20 firm fixed-price delivery order has a completion date of March 17, 2023 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,016.55 firm fixed-price delivery order is for the medical product "ENGERIX-B 20 MCG/ML SYRNML" and has a period of performance through November 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition.
AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $1,346.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564431834 ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product.
AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, with the ID SPE2DX15D6028|SPE2DX25FWFSL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,807.26 firm fixed-price delivery order is for the medical product "ENGERIX-B 10MCG 10S" and has an ultimate completion date of December 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,693.70 and an ultimate completion date of May 6, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a subdivision of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,052.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $1,176.68 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...